Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;91(1):162-163.
doi: 10.1002/ana.26258. Epub 2021 Nov 12.

Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis

Antoine Pegat #  1 , Alberto Vogrig #  2 , Charles Khouri  3 , Kamel Masmoudi  4 , Thierry Vial  5 , Emilien Bernard  1
Affiliations
Comment

Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis

Antoine Pegat et al. Ann Neurol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Nothing to report.

Figures

FIGURE 1
FIGURE 1
Frequency of facial paralysis associated with Guillain–Barré syndrome after COVID‐19 vaccine administration. WHO = World Health Organization. [Color figure can be viewed at www.annalsofneurology.org]
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Maramattom BV, Krishnan P, Paul R, et al. Guillain‐Barre syndrome following chadox1‐s/ncov ‐19 vaccine. Ann Neurol 2021;90:312–314. - PubMed
    1. Allen CM, Ramsamy S, Tarr AW, et al. Guillain‐Barre syndrome variant occurring after sars‐cov‐2 vaccination. Ann Neurol 2021;90:315–318. - PubMed
    1. Bonifacio GB, Patel D, Cook S, et al. Bilateral facial weakness with paraesthesia variant of Guillain‐Barré syndrome following Vaxzevria COVID‐19 vaccine. J Neurol Neurosurg Psychiatry (in press). 10.1136/jnnp-2021-327027 - DOI - PubMed
    1. Patel SU, Khurram R, Lakhani A, Quirk B. Guillain‐Barre syndrome following the first dose of the chimpanzee adenovirus‐vectored COVID‐19 vaccine, ChAdOx1. BMJ Case Rep 2021;14:e242956. - PMC - PubMed
    1. Márquez Loza AM, Holroyd KB, Johnson SA, et al. Guillain‐Barré syndrome in the placebo and active arms of a COVID‐19 vaccine clinical trial: temporal associations do not imply causality. Neurology 2021;96:1052–1054. - PubMed

Substances